Companies: 10,795·Total market cap: $144.5T
REMSleep Holdings, Inc.

REMSleep Holdings, Inc.

RMSLOTCHealthcare● Active
$0.00
$-0.00(-3.33%)
Market Cap$4914369
P/E Ratio
52W High$0.012
52W Low$0.0012

REMSleep Holdings, Inc. (RMSL) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

rmsl · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for REMSleep Holdings, Inc. (RMSL) measures how much investors pay for each dollar of the company's trailing earnings. RMSL's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$1926.46.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
EPS (TTM)
-$1926.46
TTM · diluted EPS
PEG Ratio
-0.00
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · REMSleep Holdings, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2007 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Devices · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
REMSleep Holdings, Inc.
REMSleep Holdings, Inc.You
RMSL
$5MN/A-$1926.46
Cardiac Biotech Solutions Inc.
Cardiac Biotech Solutions Inc.
CBSC
$4MN/A-$0.01
Canntab Therapeutics Limited
Canntab Therapeutics Limited
CTABF
$0MN/A-$0.10
Fuse Medical, Inc.
Fuse Medical, Inc.
FZMD
$2M10.25x+95.8%$0.01
Interpace Biosciences, Inc.
Interpace Biosciences, Inc.
IDXG
$47M0.22x-95.8%$5.55
IR-Med Inc.
IR-Med Inc.
IRME
$1MN/A-$0.03
Metawells Oil & Gas Inc.
Metawells Oil & Gas Inc.
KOSK
$2MN/A-$0.00
Industry Average
2 peers with valid PE
5.24xbaseline

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 19 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-1926.46
2024-12-31
FY2024
$-0.00
2023-12-31
FY2023
$-0.00
2022-12-31
FY2022
$-0.00
2021-12-31
FY2021
$-0.00
2020-12-31
FY2020
$-0.00
2019-12-31
FY2019
$-0.05
2018-12-31
FY2018
$-0.05
2017-12-31
FY2017
$-0.10
2016-12-31
FY2016
$-0.03

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for REMSleep Holdings, Inc. (RMSL) measures how much investors pay for each dollar of the company's trailing earnings. RMSL's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$1926.46.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.00 ÷ -$1926.46 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

RMSL pe ratio · 6 questions

RMSL's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$1926.46. Data sourced from Financial Modeling Prep via RMSL's SEC 10-K and 10-Q filings.

RMSL PE ratioWhat is RMSL PE ratioCurrent PE ratio of RMSLRMSL PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · REMSleep Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09